(April 9, 2024, 1:21 PM EDT) -- CAMDEN, N.J. — A pharmaceutical company and certain of its executives have agreed to settle for $97 million a securities class action by investors accusing the company of artificially inflating stock value to stave off a buyout, according to a motion for preliminary settlement approval filed by the lead plaintiff....